Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

A genetic association analysis of polymorphisms, rs2282695 and rs12373539, in the FOSB gene and papillary thyroid cancer.

Han SA, Song JY, Min SY, Park WS, Kim MJ, Chung JH, Kwon KH.

Exp Ther Med. 2012 Sep;4(3):519-523. Epub 2012 Jun 8.

2.

Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.

Eun YG, Shin IH, Kim MJ, Chung JH, Song JY, Kwon KH.

Surgery. 2012 Feb;151(2):323-9. doi: 10.1016/j.surg.2011.07.014. Epub 2011 Oct 6.

PMID:
21982075
3.

Association Study of FOS-Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population.

Kim SW, Kim CD, Chung JH, Kwon KH.

Clin Exp Otorhinolaryngol. 2014 Mar;7(1):42-6. doi: 10.3342/ceo.2014.7.1.42. Epub 2014 Feb 5.

4.

Association of the oncostatin m receptor gene polymorphisms with papillary thyroid cancer in the korean population.

Hong IK, Eun YG, Chung DH, Kwon KH, Kim DY.

Clin Exp Otorhinolaryngol. 2011 Dec;4(4):193-8. doi: 10.3342/ceo.2011.4.4.193. Epub 2011 Dec 15.

5.

Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillary thyroid cancer.

Kwon KH, Lee YC, Chung JH, Eun YG.

J Invest Surg. 2013 Dec;26(6):319-24. doi: 10.3109/08941939.2013.805857. Epub 2013 Aug 19.

PMID:
23957698
6.

Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.

Park SW, Kim MK, Kwon KH, Kim J.

Int J Immunogenet. 2012 Dec;39(6):501-7. doi: 10.1111/j.1744-313X.2012.01125.x. Epub 2012 May 18.

PMID:
22594576
7.

Polymorphisms in bone morphogenetic protein 3 and the risk of papillary thyroid cancer.

Kim YO, Hong IK, Eun YG, Nah SS, Lee S, Heo SH, Kim HK, Song HY, Kim HJ.

Oncol Lett. 2013 Jan;5(1):336-340. Epub 2012 Oct 10.

8.

Association between collagen type XI α1 gene polymorphisms and papillary thyroid cancer in a Korean population.

Park HJ, Choe BK, Kim SK, Park HK, Kim JW, Chung JH, Hong IK, Chung DH, Kwon KH.

Exp Ther Med. 2011 Nov;2(6):1111-1116. Epub 2011 Jul 14.

9.

Interleukin 22 polymorphisms and papillary thyroid cancer.

Eun YG, Shin IH, Lee YC, Shin SY, Kim SK, Chung JH, Kwon KH.

J Endocrinol Invest. 2013 Sep;36(8):584-7. doi: 10.3275/8879. Epub 2013 Feb 27.

PMID:
23448944
10.

Missense polymorphisms in XIAP-associated factor-1 (XAF1) and risk of papillary thyroid cancer: correlation with clinicopathological features.

Kim SK, Park HJ, Seok H, Jeon HS, Kim JW, Chung JH, Kwon KH, Woo SH, Lee BW, Baik HH.

Anticancer Res. 2013 May;33(5):2205-10.

PMID:
23645777
11.

A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population.

Kim SK, Kim DK, Oh IH, Song JY, Kwon KH, Choe BK, Kim YH.

J Korean Surg Soc. 2011 Nov;81(5):308-15. doi: 10.4174/jkss.2011.81.5.308. Epub 2011 Nov 1.

12.

PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer.

Kim MJ, Kim SK, Park HJ, Chung DH, Park HK, Lee JS, Kwon KH, Chung JH.

Mol Med Rep. 2012 May;5(5):1267-70. doi: 10.3892/mmr.2012.784. Epub 2012 Feb 10.

PMID:
22327316
13.

Association study of integrins beta 1 and beta 2 gene polymorphism and papillary thyroid cancer.

Eun YG, Kim SK, Chung JH, Kwon KH.

Am J Surg. 2013 Jun;205(6):631-5. doi: 10.1016/j.amjsurg.2012.05.035. Epub 2013 Feb 4.

PMID:
23388428
14.

Association of CFTR gene polymorphisms with papillary thyroid cancer.

Oh IH, Oh C, Yoon TY, Choi JM, Kim SK, Park HJ, Eun YG, Chung DH, Kwon KH, Choe BK.

Oncol Lett. 2012 Feb;3(2):455-461. Epub 2011 Nov 15.

15.

Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.

Kim MK, Park SW, Kim SK, Park HJ, Eun YG, Kwon KH, Kim J.

J Korean Med Sci. 2012 Nov;27(11):1333-8. doi: 10.3346/jkms.2012.27.11.1333. Epub 2012 Oct 30.

16.

Single nucleotide polymorphisms of the Fas gene are associated with papillary thyroid cancer.

Eun YG, Lee YC, Kim SK, Chung JH, Kwon KH, Park IS.

Auris Nasus Larynx. 2015 Aug;42(4):326-31. doi: 10.1016/j.anl.2015.02.001. Epub 2015 Mar 29.

PMID:
25824544
17.

Interleukin-1 beta polymorphisms are associated with lymph node metastasis in Korean patients with papillary thyroid carcinoma.

Ban JY, Kim MK, Park SW, Kwon KH.

Immunol Invest. 2012;41(8):888-905. doi: 10.3109/08820139.2012.724751.

PMID:
23215728
18.

A Fas-associated via death domain promoter polymorphism (rs10898853, -16C/T) as a risk factor for papillary thyroid cancer.

Eun YG, Chung DH, Kim SW, Lee YC, Kim SK, Kwon KH.

Eur Surg Res. 2014;52(1-2):1-7. doi: 10.1159/000355878. Epub 2014 Jan 16.

PMID:
24434721
19.

A Polymorphism (rs1801018, Thr7Thr) of BCL2 is Associated with Papillary Thyroid Cancer in Korean Population.

Eun YG, Hong IK, Kim SK, Park HK, Kwon S, Chung DH, Kwon KH.

Clin Exp Otorhinolaryngol. 2011 Sep;4(3):149-54. doi: 10.3342/ceo.2011.4.3.149. Epub 2011 Sep 6.

20.

Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.

Yuan Q, Bu Q, Li G, Zhang J, Cui T, Zhu R, Mu D.

Clin Endocrinol (Oxf). 2016 Apr;84(4):564-70. doi: 10.1111/cen.12832. Epub 2015 Aug 14.

PMID:
26052935
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk